Cytoreduction Surgical Procedures
"Cytoreduction Surgical Procedures" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Operative procedures carried out to reduce a mass of tissue, for example, to reduce the total amount of tissue composing a tumor.
| Descriptor ID |
D065426
|
| MeSH Number(s) |
E04.166
|
| Concept/Terms |
Cytoreduction Surgical Procedures- Cytoreduction Surgical Procedures
- Cytoreduction Surgical Procedure
- Procedure, Cytoreduction Surgical
- Surgical Procedure, Cytoreduction
- Debulking Surgical Procedures
- Debulking Surgical Procedure
- Procedure, Debulking Surgical
- Surgical Procedure, Debulking
- Cytoreductive Surgery
- Cytoreductive Surgeries
- Surgery, Cytoreductive
- Cytoreductive Surgical Procedures
- Cytoreductive Surgical Procedure
- Procedure, Cytoreductive Surgical
- Surgical Procedure, Cytoreductive
- Surgical Procedures, Cytoreductive
|
Below are MeSH descriptors whose meaning is more general than "Cytoreduction Surgical Procedures".
Below are MeSH descriptors whose meaning is more specific than "Cytoreduction Surgical Procedures".
This graph shows the total number of publications written about "Cytoreduction Surgical Procedures" by people in this website by year, and whether "Cytoreduction Surgical Procedures" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 2 | 1 | 3 |
| 2015 | 8 | 4 | 12 |
| 2016 | 5 | 4 | 9 |
| 2017 | 11 | 8 | 19 |
| 2018 | 13 | 4 | 17 |
| 2019 | 20 | 7 | 27 |
| 2020 | 13 | 21 | 34 |
| 2021 | 7 | 11 | 18 |
| 2022 | 4 | 12 | 16 |
| 2023 | 0 | 5 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cytoreduction Surgical Procedures" by people in Profiles.
-
ASO Visual Abstract: Cytoreduction and HIPEC for Gastric Carcinomatosis: Multi-institutional Analysis of Two Phase II Clinical Trials. Ann Surg Oncol. 2023 03; 30(3):1861-1862.
-
ASO Visual Abstract: Conditional Survival After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC Collaborative. Ann Surg Oncol. 2023 03; 30(3):1850-1851.
-
Prognostic significance of acellular mucin in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) for appendiceal neoplasms. Langenbecks Arch Surg. 2023 Feb 28; 408(1):110.
-
Laparoscopic secondary cytoreductive surgery: let's not make the same assumptions. Int J Gynecol Cancer. 2023 02 06; 33(2):145-146.
-
Transfusion use and effect on progression-free, overall survival, and quality of life in upfront treatment of advanced epithelial ovarian cancer: evaluation of the European Organization for Research and Treatment EORTC-55971 Cohort. Int J Gynecol Cancer. 2023 01 03; 33(1):1-9.
-
Patient outcomes following interval and delayed cytoreductive surgery in advanced ovarian cancer: protocol for a multicenter, international, cohort study (Global Gynaecological Oncology Surgical Outcomes Collaborative). Int J Gynecol Cancer. 2022 12 05; 32(12):1606-1610.
-
Influence of insurance status on the postoperative outcomes of cytoreductive surgery and HIPEC. J Surg Oncol. 2023 Mar; 127(4):706-715.
-
Cytoreduction and HIPEC for Gastric Carcinomatosis: Multi-institutional Analysis of Two Phase II Clinical Trials. Ann Surg Oncol. 2023 Mar; 30(3):1852-1860.
-
Conditional Survival Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC Collaborative. Ann Surg Oncol. 2023 Mar; 30(3):1840-1849.
-
Do Lymph Node Metastases Matter in Appendiceal Cancer with Peritoneal Carcinomatosis? A US HIPEC Collaborative Study. J Gastrointest Surg. 2022 12; 26(12):2569-2578.